Product Information

TACLONEX 0.005%-0.064% SUSPENSION is a brand product labeled by LEO Pharma Inc., priced at $20.7168 per GM under NDC 50222050166. Its NADAC has been published 579 times since Dec 18, 2013.

FDA first approved this application on May 9, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the calcipotriene and betamethasone dipropionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for TACLONEX 0.005%-0.064% SUSPENSION has been published 579 times since Dec 18, 2013, and over the history we have for it it has risen 107.5%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.